The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and virtually, and saw leading hemonc experts from all over the world gather to showcase the latest research in hematological malignancies.
What a pleasant surprise to see my @CccLmu @LMU_Muenchen colleague @KRejeski pop up on @VJHemOnc discussing the CAR-HEMATOTOX score developed by our departments @LMU_Immutherapy group led by @MSubklewe .
#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and virtually, and saw leading hemonc experts from all over the world gather to showcase the latest research in hematological malignancies.
What a pleasant surprise to see my @CccLmu @LMU_Muenchen colleague @KRejeski pop up on @VJHemOnc discussing the CAR-HEMATOTOX score developed by our departments @LMU_Immutherapy group led by @MSubklewe .
#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.
Discover the latest updates in immuno-oncology, including CAR-T cell therapy, antibodies, and more, with our expert interviews, podcasts, and sessions.